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Abstract
Background: Human central nervous system-stem cells grown as neurospheres (hCNS-SCns) self-renew, are multipotent,
and have potential therapeutic applications following trauma to the spinal cord. We have previously shown locomotor
recovery in immunodeficient mice that received a moderate contusion spinal cord injury (SCI) and hCNS-SCns
transplantation 9 days post-injury (dpi). Engrafted hCNS-SCns exhibited terminal differentiation to myelinating
oligodendrocytes and synapse-forming neurons. Further, selective ablation of human cells using Diphtheria toxin (DT)
abolished locomotor recovery in this paradigm, suggesting integration of human cells within the mouse host as a possible
mechanism for the locomotor improvement. However, the hypothesis that hCNS-SCns could alter the host
microenvironment as an additional or alternative mechanism of recovery remained unexplored; we tested that hypothesis
in the present study.
Methods and Findings: Stereological quantification of human cells using a human-specific cytoplasmic marker
demonstrated successful cell engraftment, survival, migration and limited proliferation in all hCNS-SCns transplanted
animals. DT administration at 16 weeks post-transplant ablated 80.5% of hCNS-SCns. Stereological quantification for lesion
volume, tissue sparing, descending serotonergic host fiber sprouting, chondroitin sulfate proteoglycan deposition, glial
scarring, and angiogenesis demonstrated no evidence of host modification within the mouse spinal cord as a result of
hCNS-SCns transplantation. Biochemical analyses supplemented stereological data supporting the absence of neural stem-
cell mediated host repair. However, linear regression analysis of the number of engrafted hCNS-SCns vs. the number of
errors on a horizontal ladder beam task revealed a strong correlation between these variables (r=20.78, p,0.05),
suggesting that survival and engraftment were directly related to a quantitative measure of recovery.
Conclusions: Altogether, the data suggest that the locomotor improvements associated with hCNS-SCns transplantation
were not due to modifications within the host microenvironment, supporting the hypothesis that human cell integration
within the host circuitry mediates functional recovery following a 9 day delayed transplant.
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Introduction
The endogenous capacity of the spinal cord for repair and
regeneration following traumatic injury is thought to be limited.
Accordingly, stem cell transplantation is one potential strategy for
promoting recovery of function after spinal cord injury (SCI).
Rodent- and human-derived neural/glial cell populations trans-
planted sub-acutely after SCI have been associated with recovery
of function in several studies [1–6]. In these studies, remyelination
was suggested as the primary mechanism for the observed
locomotor improvement. Two groups have found evidence for
integration of transplanted human fetal/adult neural stem cells as
new neurons following SCI [1,7], potentially promoting restora-
tion of disrupted circuitry. While all the studies above suggest cell
integration by means of oligodendroglial and neuronal differen-
tiation as potential mechanisms for recovery of function after SCI,
the possibility of additional mechanisms whereby engrafted cell
populations contribute to endogenous repair within the host
microenvironment remains unexplored.
Though the presumptive strategy behind transplantation of
stem cell populations for SCI has been replacement via integration
of myelinating oligodendrocytes or new neurons, the ability of
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5871transplanted cell populations to affect the host niche following SCI
is becoming increasingly clear. Genetically modified fibroblasts,
olfactory ensheathing cells (OECs), Schwann cells, and neural
stem cells (NSCs) have been reported to promote host axonal
regeneration [8–14]. Transplantation of oligodendrocyte progen-
itor cells (OPCs) after SCI has been shown to promote white
matter sparing [15]. Similarly, implantation of a polymer scaffold
containing NSCs in the contused rat cord has been reported to
reduce tissue loss and glial scarring [16], and transplantation of
glial-restricted progenitors (GRPs) have been shown to reduce
astroglial scarring and chondroitin sulfate proteoglycan (CSPG)
deposition as early as 8 days post-transplant [13]. Other studies
using GRPs have also reported modifications altering the
permissiveness of the post-SCI microenvironment and promotion
of regeneration [17]. Understanding the alternative mechanisms
by which cell-based therapies may affect SCI will be critical in
understanding how transplanted cells may affect functional
recovery in a clinical setting.
Previously, our laboratory investigated the potential for human
CNS-stem cells isolated from brain tissue (gestational 16–20 weeks)
and grown as neurospheres (hCNS-SCns) to mediate recovery after
SCI [1]. Stable hCNS-SCns lines were isolated using fluorescence-
activated cell sorting (FACS) to identify a CD133
+ and CD24
2/lo
population [18], which enriches the number of cells in the
population with neurosphere-initiating capacity approximately
2000-fold. Cells derived in this manner retain multipotency and
generate neurons, astrocytes, and oligodendrocytes in vitro and in vivo
[18,19]. We have previously shown locomotor recovery in
immunodeficient Non-Obese Diabetic-severe combined immunodeficient
(NOD-scid) mice that received either a 50 or 60 kilodyne (kd)
contusion SCI, followed by hCNS-SCns transplantation 9 days
post-injury (dpi) [1]. Critically, NOD-scid mice enable xenogeneic
transplantation without rejection/immunosuppressant drug admin-
istration, and allow achievement of 100% engraftment not seen in
other models. Engrafted hCNS-SCns exhibited terminal differen-
tiation into myelinating oligodendrocytes and synapse-forming
neurons. Further, ablation of human cells using Diphtheria toxin
(DT) abolished recovery in this paradigm, suggesting that cell
survival is required for maintaining locomotor improvement and
that integration of human cells within the mouse host is one possible
mechanism for the observed recovery. However, the hypothesis that
hCNS-SCns could also alter the host microenvironment as an
additional mechanism was not investigated.
The current study is a stereological analysis of hCNS-SCns
engraftment and the efficacy of DT ablation not previously
published, in the 60 kd cohort, and additionally uses stereological
analyses to test the alternative hypothesis that 9 day delayed
hCNS-SCns transplantation modifies the local microenvironment
in relationship to the following parameters: lesion volume, tissue
sparing, descending serotonergic (5-HT) host fiber sprouting, NG2
deposition, GFAP glial scarring, and angiogenesis. Our results
show no evidence of host modifications in association with hCNS-
SCns transplantation. Further, biochemical analyses supplement
stereological data and demonstrate no changes in Fibronectin,
Versican, GFAP, NG2, and PE-CAM1 protein expression at 2
weeks post-transplant. Linear regression analysis of the number of
engrafted hCNS-SCns versus the number of errors on a horizontal
ladder beam task reveal a correlation between these variables,
suggesting that survival/successful engraftment of hCNS-SCns is
directly related to a quantitative measure of recovery. Altogether,
our data suggest that integration of transplanted hCNS-SCns
within the host circuitry mediates locomotor recovery in the 9 day
delayed transplantation paradigm, and cell engraftment is unlikely
to be associated with host niche modifications.
Materials and Methods
Ethics statement
All animal housing conditions, surgical procedures, and
postoperative care was conducted according to the Institutional
Animal Care and Use Committee (IACUC) guidelines at the
University of California, Irvine.
Contusion injuries
Female NOD-scid mice (10 weeks old; StemCells, Inc., Palo
Alto, CA) were anesthetized with Avertin (0.5 ml/20 g tribromo-
ethanol) intraperitoneally (i.p.), and received a laminectomy at
vertebral level thoracic 9 (T9) using a surgical microscope.
Animals (n=65) received 60 kd (1 dyne=10 mN) contusion
injuries using the Infinite Horizon (IH) Imapctor (Precision
Systems and Instrumentation. Lexington, KY). This 60 kd
contusion injury resulted in average 2dpi open-field scores of
1.460.6 and 5.261.9 (S.D.) on the BMS and BBB scales,
respectively. Average open-field locomotor scores at 7dpi were
3.161.0 and 8.362.2 on the BMS and BBB scales, respectively.
Immediately after injury, the muscle was closed with 5–0 chromic
gut sutures and the skin closed with wound clips. Animals received
lactated ringers (50 ml/kg) sub-cutaneously (s.c.) immediately after
surgery and for 3–5 days post surgery, and Buprenorphine
(0.5 mg/kg s.c.) immediately after injury and for 2 days thereafter.
Due to the immunodeficient nature of NOD-scid mice, and to
avoid the possibility of bladder infections, antibiotics were
administered daily throughout the duration of the study, rotating
the use of Baytril, Ciproflaxacin, and Ampicillin (2.5 mg/kg s.c.,
dose for all drugs) every two weeks.
Cell transplantation
Four mice were excluded at the time of initial SCI surgery due
to unilateral bruising or abnormal force/displacement curves.
Seven days post-SCI, the remaining 61 animals were behaviorally
assessed using the open-field Basso, Beattie, and Bresnahan (BBB)
and Basso Mouse Scale (BMS) rating scales to confirm contusion
injury severity. Based on pre-transplantation open-field scores,
animals were randomly assigned to receive either hCNS-SCns
(average group scores of 3.1560.65 and 10.0660.89, BMS and
BBB, respectively), human fibroblasts (hFb) (average group scores
of 3.0960.71 and 9.3262.12, BMS and BBB, respectively), or
vehicle injections (average group scores of 2.8960.92 and
9.7861.69, BMS and BBB, respectively); this procedure ensured
all groups were composed of a set of animals in which the pre-
transplantation mean and variance in scores (i.e. standard
deviations) were equivalent.
Long-term human neurosphere cultures isolated from brain
tissue (gestational 16–20 weeks) have been described previously
[18]. Briefly, FACS-sorted single cell suspensions were cultured in
neurosphere initiation medium consisting of Ex-Vivo 15 medium
with N2 supplement, FGF, EGF, LIF, neural survival factor-1, and
NAC. Cultures were fed weekly and passaged every 2–3 weeks
[1,18]. Human fibroblasts were isolated from fetal liver and grown
in Isocove’s modified Dulbecco’s medium containing 10% FBS,
and passaged upon confluence [1]. On the day of transplantation,
neurospheres and confluent hFb cultures were dissociated into a
single-cell suspension and concentrated to a final density of
75,000 hCNS-SCns/ml of injection buffer containing 50% Hank’s
buffered salt solution and 50% Ex-Vivo medium and 50,000 hFb/
ml of injection buffer. Nine days after SCI, mice were re-
anesthetized, the laminectomy site re-exposed, and the animals
were secured in a spinal stereotaxic frame by clamping the T8 and
T10 lateral vertebral processes. Polished siliconized beveled glass
Mechanisms of Host Repair
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ments, Novato, CA) were loaded with freshly triturated cells,
which were injected using a NanoInjector system and microposi-
tioner (WPI Instruments, Waltham, MA). Animals received four
injections bilaterally 0.75 mm from midline and into the intact
parenchyma adjacent to the contusion site; cells were injected in
two sites at the anterior aspect of T10 and in two sites at the
posterior aspect of T8 (Fig. 1). Each site received 250 nl of hCNS-
SCns or hFb or vehicle (injection buffer), for a total volume of 1 ml,
delivered in 50 nl puffs over 75 s, followed by a 2 min delay before
withdrawal of the pipette. Previous studies in our laboratory have
demonstrated that this volume does not exacerbate damage to the
spinal cord.
Behavioral Assessment
The BMS and the modified BBB rating scales [20,21], as well as
the horizontal ladderbeam task [22] were used to assess behavioral
recovery. All analyses were performed by observers blinded to
treatment groups. Behavioral results have been published
previously [1] and that data is used only for correlative analysis
in the present study.
Human cell ablation using Diphtheria toxin
After BBB/BMS assessment 16 weeks post-transplant, a subset
of mice in each group, were randomly assigned to receive two
injections of Diphtheria toxin (DT) (50 mg/kg, i.p.) 24 h apart
(average BBB/BMS scores prior to DT administration: hCNS-
SCns 10.3560.88/3.9361.65; hFb 10.0060.91/3.3861.62; ve-
hicle 9.4262.49/3.5861.44). DT was used to selectively ablate
human cells, which are 10,000 fold more sensitive to DT than
mouse cells [23,24]. The remaining animals received an equal
volume of saline. All animals in the study were reassessed on the
BBB/BMS, and the ladderbeam task 1 week after DT or saline
administration.
Perfusions and tissue collection
All animals (n=48) were transcardially perfused 17 weeks post-
transplant. A total of 13 animals were excluded from the study by
technicians blinded to experimental groups. Exclusion criteria
included kyphosis, death during the transplantation procedure,
death during the study (thymic lymphoma at autopsy), and illness.
Thymic lymphomas occur with high frequency in NOD-scid mice
and lifespan is typically limited to 8 months under specific pathogen-
free conditions [25]. Mice (n=48) were anesthetized with a lethal
dose of sodium pentobarbital (100 mg/kg, i.p.) and transcardially
perfused with 30 ml of PBS, followed by 100 ml of 4% paraformal-
dehyde. Brains and spinal cords were dissected. Spinal cord regions
corresponding to T1-T5, T6-T12, and T13-L2 vertebrae were post-
fixed overnight in 4% paraformaldehyde, flash frozen at 265uCi n
isopentane (2-methyl butane), and stored at 280uC.
Immunostaining
The T6-T12 spinal cord regions were embedded in optimal
cutting temperature compound (Tissue-Tek). 30 mm thick para-
sagittal sections were cut on a sliding microtome, collected in 96-
well plates containing 0.1 M Tris and 0.02% Sodium Azide, and
kept at 4uC until processed for immunostaining. All immuno-
staining procedures were conducted at room temperature. A total
of five randomly selected animals were excluded from all
stereological analyses and utilized solely to establish experimental
parameters: these animals were used to optimize histological
procedures and determine antibody titrations.
Immunostaining was performed as previously described [26].
Briefly, sections were washed in 0.1 M Tris followed by incubation
in 0.3% hydrogen peroxide/methanol. After a brief 0.1%
TritonX-100 wash, sections were blocked with bovine serum
albumine (BSA) and normal serum from the species in which the
secondary antibody was raised. Sections were then exposed
overnight to the appropriate antibody (Table 1). The next day,
sections were incubated with a biotin-conjugated, purified IgG
secondary antibody (1:500, Jackson Immunoresearch) pre-ad-
sorbed against the species in which the primary was raised (See
Table 1), followed by the avidin-biotinylated peroxidase complex
(ABC) using the Vectastain Elite ABC kit (Vector Laboratories,
USA) and prepared according to the manufacturer’s recommen-
dations. After several washes, the signal was visualized with
diaminobenzidine (DAB) (Vector Laboratories, USA). Sections
were mounted onto slides and allowed to dry overnight. SC121
and GFAP-stained sections were lightly counterstained with the
nuclear marker, methyl green. PE-CAM1-stained sections were
counterstained with Hoechst 33342 (1:1000, Invitrogen) to identify
the lesion epicenter without interference of nuclei in brightfield.
All slides were dehydrated and coverslipped using Depex
mounting medium.
Figure 1. Schematic of spinal cord illustrates regions of stereological quantification for human cell numbers. Illustration depicts the
five regions (lesion epicenter, spared tissue, 1 mm rostral and caudal, 2 mm rostral and caudal, 3 mm rostral and caudal) in which stereological
quantification of hCNS-SCns and hFb counts were performed. Sites of cell transplantation in the two regions rostral and caudal to the lesion epicenter
are also shown.
doi:10.1371/journal.pone.0005871.g001
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An Olympus BX51 microscope with motorized stage and
StereoInvestigator (Version 6.3 Software, Microbrightfield, Will-
iston, VT) were used to stereologically estimate unbiased total cell
numbers, cell migration, lesion volume, volume of spared tissue,
serotonergic fiber length, NG2 and GFAP areas, and blood vessel
length. Animals containing less than three sections with a visible
injury epicenter (minimum number required for obtaining reliable
results) were excluded from stereological analyses (Table 2).
Uniform random sampling of the tissue was performed according
to standard stereological principles (see details for individual
parameters below). Starting sections were chosen at random and
sections were spaced 180 mm apart. Sampling parameters (i.e. grid
size and counting frame size) were empirically determined to
arrive at low coefficients of error (CE) for each measure. CE values
are summarized in Table 3. Additionally, post-hoc power analysis
[27,28] of stereological data collected in previous publications
from our laboratory demonstrated that stereological quantification
of lesion volume [29] and serotonergic fiber sprouting [30], even
with a relatively small sample size, detects medium (f/d.0.5) and
large effects (f/d.0.75) with adequate statistical power (Table 4),
suggesting that the methodology utilized in those studies was
sensitive for detection of medium and large differences [28]. In the
current study, it was estimated that the detection of a small effect
(f=0.25) with high statistical power (power=0.95), would have
required a starting total sample size of 252 animals- a number that
would have been neither justifiable, nor practical in an in vivo
setting. Accordingly, we performed a compromise analysis to meet
the demands of an adequate power with a given sample size and
fixed effect size, to determine whether the sample sizes in the
current study were sufficient to detect small differences with
adequate statistical power. Using the sample sizes in the present
study (a minimum of n=29 for PE-CAM1 and a maximum of
n=42 for GFAP scar, spared tissue, and raphespinal fibers), a
small effect of f=0.25 could have been detected with adequate
statistical power of 0.63 at a minimum and 0.67 at a maximum–a
power that is comparable to our previously published data where
statistically significant differences were detected between groups.
Thus, the study design and the stereoglocial quantification
techniques utilized in the present study would be predicted to
have sufficient statistical power to detect even small differences
between groups with adequate power.
Cell number
The Optical Fractionator probe [31,32] was used to quantify
the number of human cells. The counting areas were determined
by drawing contours around five different regions (1 mm, 2 mm,
3 mm, epicenter and spared tissue) of the spinal cord using a 46
Table 1. List of antibodies used for histological and stereological assessments.
Antibody Host Dilution Manufacturer Specificity
SC121 Mouse 1:3000 (hCNS-SCns) 1:1000 (hFb) StemCells, Inc. Human Cytoplasm
GFAP Rabbit 1:60,000 DAKO GFAP-positive Astrocytes
NG2 Rabbit 1:1000 Chemicon CSPG (NG2) Deposition
5-HT Rabbit 1:15,000 Sigma Serotonergic Fibers
PE-CAM1 Rat 1:200 Pharmingen Endothelial Cells
doi:10.1371/journal.pone.0005871.t001
Table 2. Number of animals analyzed for individual markers using StereoInvestigator.





Saline DT Saline DT Saline DT Saline DT Saline DT Saline DT Saline DT
Vehicle 00 75 76 78 77 74 4 4
hFb 76 76 76 75 76 66 5 5
hCNS-
SCns
78 78 78 78 78 68 4 7
Only animals containing three or more sections in which the injury epicenters were visible were included in the analyses.
doi:10.1371/journal.pone.0005871.t002
















Mean Coefficient of Error (CE) ,0.01/,1p e r
region
0.0342 0.0281 0.1184 0.0301 0.0222 0.067/0.088
doi:10.1371/journal.pone.0005871.t003
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nuclei were counted using a 1006 objective in each contour.
Quantification in StereoInvestigator yielded the total number of
SC121-positive cells within each region. Estimated Optical
Fractionator count was calculated as the sum of cells in all five
regions. While engrafted hCNS-SCns migrated extensively away
from the injury epicenter, our tissue collection techniques for this
experiment did not include a clear marking of the rostral/caudal
ends of the spinal cord, and thus, we were unable to assess
direction-specific migration of hCNS-SCns (i.e. number of cells
present in the rostral vs. caudal segment of the spinal cord).
Therefore, in the present study, the total number of cells in each of
the regions illustrated in Fig. 1 was quantified, and the sum of cell
numbers for each region and in both directions was defined as the
estimated number of cells in each region.
Fiber/vessel length
Serotonergic fiber length was quantified using the Isotropic
Virtual Planes (IVP) probe of StereoInvestigator [33]. A 500 mm
long contour was drawn from the caudal edge of the lesion
epicenter. Fiber intersects were counted using unbiased, systematic
sampling using a 606 objective with a counting frame size of
50 mm650 mm, grid size of 130 mm6200 mm, and virtual plane
separation of 7.0 mm [30]. Results yielded the estimated 5-HT
fiber length within this predefined 500 mm region.
Blood vessel length was quantified using the Space Balls probe
of StereoInvestigator, which allows for quantification of fibers/
vessels with wide diameters as was the case with PE-CAM1-
positive vessels. Contours were drawn around the injury epicenter
(identified by dense Hoechst staining) as well as regions 1 mm
rostral and 1 mm caudal to the edge of the lesion site. Fiber
intersects with a hemisphere with a 12 mm radius were counted
using a 406 objective. Grid sizes of 50 mm650 mm and
200 mm6200 mm were used at the lesion site and 1 mm regions,
respectively. Results yielded estimated blood vessel length in each
region.
Area and volume analyses
Area and volume analyses were performed using Cavalieri
estimator probe in StereoInvestigator [34,35]. Lesion volume and
volume of spared tissue were performed using GFAP immuno-
stained sections. The region devoid of GFAP was identified as the
lesion epicenter and areas 1 mm rostral and 1 mm caudal to the
epicenter were defined as spared tissue. A point-grid of known
spacing (100 mm apart) was randomly overlayed on the section
image. Points were counted using a 206 objective within the
region of interest. This analysis yielded the estimated lesion
volume and volume of spared tissue.
Stereological analyses for GFAP astrogliosis and NG2 deposi-
tion were performed in spinal cord sections containing a visible
injury epicenter. While astrogliosis and NG2 deposition are not
limited to sections containing the injury epicenter, in the absence
of a visible injury epicenter, the widespread expression of both
proteins along the spinal cord makes the analysis of these
parameters challenging. Accordingly, stereological analyses for
the GFAP scar and NG2 deposition could only be performed in
sections with a visible injury epicenter where the dense plexus of
astrocytes as well as the NG2 proteoglycan could be reliably
identified. Immunostaining for each marker was performed in
30 mm parasagittal spinal cord sections according to the
stereological principles described above (one in six sections),
resulting in an average of 4 sections, per marker, that contained a
visible injury epicenter. Given the limited number of sections
available for the analyses, volume estimation of astrogliosis and
NG2 deposition would have resulted in high variability. Therefore,
stereological analyses for these two parameters are reported as a
measure of area, not volume. Area sampling was performed using
the Cavalieri estimator probe. GFAP-occupied scar tissue was
assessed using dense GFAP staining around the site of injury. A
point grid of known sampling (100 mm apart) was randomly
overlayed on the section image. Points were counted using a 106
objective within the region of interest. This analysis yielded the
estimated area occupied by the GFAP scar or the NG2
proteogylcan.
Biochemical protein analysis
A separate cohort of female NOD-scid mice (10 weeks old;
StemCells, Inc., Palo Alto, CA) received 60 kd contusion injuries
(n=6) at T9 for biochemical analysis of protein expression
following hCNS-SCns transplantation. All surgical and post-
operation animal care procedures were identical to the method-
ology described above. At 7dpi, animals were behaviorally assessed
using the open-field Basso Mouse Scale (BMS) rating scale to
confirm contusion injury severity, and based on pre-transplanta-
tion open-field scores, animals were randomly assigned to receive
either hCNS-SCns (average BMS score of 3.5861.4) or vehicle
(average BMS score of 4.5061.87) injections.
At 9dpi, mice were re-anesthetized, the laminectomy site re-
exposed, and the animals received four injections of either hCNS-
SCns (n=3) or vehicle control (n=3) bilaterally 0.75 mm from
midline and into the intact parenchyma adjacent to the contusion
site; cells were injected in two sites at the anterior aspect of T10
and in two sites at the posterior aspect of T8 (Fig. 1). All surgical
and post-transplantation animal care procedures were identical to
the methodology described above.
Two weeks following transplantation, mice were anesthetized
with a lethal dose of Euthasol. Spinal cord tissue corresponding to
T7 and T11 dorsal roots was freshly dissected, and immediately
placed on dry ice and stored at 280uC. Protein extraction was
performed using Western blot buffer (1 M Tris-HCl containing
Table 4. Post-hoc power analysis to determine statistical power of the stereological quantifications performed in two previous
publications from our laboratory.





Engesser-Cesar et al. 2007 Reaphespinal fiber l
ength
f=0.671
* 0.05 3 19 0.66
Galvan et al. 2008 Lesion volume d=1.766
# 0.05 2 15 0.69
*Effect size, f, was determined using one-way ANOVA to compare multiple groups.
#Effect size, d, was determined using Student’s t-tests to compare between two groups.
doi:10.1371/journal.pone.0005871.t004
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inhibitors added immediately before extraction, and at a pH of
6.8). Spinal cord tissue from all animals was manually homoge-
nized, centrifuged at 13,000 rpm, and the protein samples were
standardized to a concentration of 0.20 mg/ml using a Bradford
Assay. A total of 16 mg of protein was loaded onto Nupage Novex
3–8% Tris-acetate gel or 10% Nupage Bis-Tris gel, separated by
SDS/PAGE, and transferred to PVDF membranes by electro-
phoresis. The membranes were washed in 1 M Tris-buffered
saline (TBS), pH 7.2–7.4, followed by Tris-buffered saline
containing 3% milk and 0.01% Tween-20 (TBST), pH 7.2–7.4,
for 1 hr. Primary antibodies for each antigen at the appropriate
dilutions (Table 5) were added to the membranes and incubated
for 2 hrs at room temperature. The membranes were washed with
TBS, blocked with TBST and incubated with the appropriate
secondary antibody for 1 hr (Table 5). The blots were then washed
with TBS, and blocked with TBST. In a final step, the blots were
either incubated with ECL solution (GE Healthcare) and signal
was detected on Hyperfilm-ECL (GE Healthcare) or the blots were
incubated with Avidin-Biotin Complex for 30 minutes and signal
was visualized using the VIP Peroxidase kit (Vector Laboratories).
Protein levels were quantified by an individual blinded to
experimental groups using ImageJ (Version 10.2) gel analyzer.
Statistical analysis
All behavioral, histological, stereological, and biochemical
analyses were performed by experimenters blinded to the
experimental groups. Statistical analyses were performed using
Statview (Version 5.0.1 Software) and Prism (Version 4.0a
Software). Power analyses were performed using G*Power
(Version 3.0.10 Software). All stereological quantifications for
measures of host recovery were analyzed using one-way ANOVA
to compare differences between the three groups. Biochemical
protein levels (western blots) were analyzed using two-tailed
Student’s t-tests to compare differences between two groups.
Linear regression analysis was performed with Pearson correlation,
followed by the appropriate t-tests. Significance was defined as
p,0.05 in all statistical analyses.
Results
Cell engraftment and survival in animals receiving saline
at 16 weeks post-transplant
One of the challenges associated with any cell transplantation
strategy, especially in a xenograft paradigm, is the ability to
overcome the host immune response and obtain successful cell
engraftment. In the present study, we used immunodeficient
NOD-scid mice to reduce confounds of xenograft rejection, avoid
immunosuppressant drugs, and enhance hCNS-SCns engraftment
success. Immunostaining using the human-specific cytoplasmic
marker, SC121, revealed that hCNS-SCns engrafted in 100% of
the animals, and that engrafted cells survived 17 weeks post-
transplant (Fig. 2A). Engrafted hCNS-SCns migrated along the
spinal cord and appeared to differentiate in a site-specific manner
consistent with neuronal and oligodendroglial morphologies in the
grey and white matter, respectively (Fig. 2B). Confocal analysis of
hCNS-SCns differentiation was not repeated in the present study
but was performed in our previous publication [1], where we
reported evidence for b-tubulin or APC/CC1 expression in 26.4%
and 64.1% of engrafted hCNS-SCns, respectively. hFb also
engrafted in 100% of the animals and survived 17 weeks post-
transplant (Fig. 2C). In contrast to hCNS-SCns, engrafted hFb
were highly localized to the region corresponding to the site of
transplantation and exhibited limited migration (Fig. 2C and D).
Stereological quantification for the total number of engrafted
cells demonstrated an average of 145,553 hCNS-SCns in
comparison to the 75,000 cells originally transplanted (194% of
the initial transplant dose), suggesting limited proliferation (Fig 2E).
Notably, no evidence of tumorogenesis or increased mortality in
the transplanted versus non-transplanted animals was observed
during the total duration of the study. Addtionally, stereological
quantification demonstrated an average of 3,752 hFb in
comparison to the 50,000 cells originally transplanted (7.5% of
the initial transplant dose), suggesting that the spinal cord niche is
not a favorable environment for hFb survival (Fig. 2E).
Cell migration in animals receiving saline at 16 weeks
post-transplant
Effective therapeutic remyelination after SCI may only be
possible if the transplanted cell population is capable of extensive
migration, enabling cells to reach demyelinated and/or dysmye-
linated axons above and below the primary injury. To investigate
cell migration, we analyzed the number of human cells at different
regions along the spinal cord (see Methods) and found that both
hCNS-SCns and hFb migrated at least 3 mm, in each direction
from the edge of the lesion, but significantly more hCNS-SCns
were found at greater distances from the epicenter in comparison
to hFb (Fig. 3A and B). hCNS-SCns were clearly observed to have
migrated beyond 3 mm, however, in order to preserve stereolog-
ical consistency, only cells within regions 3 mm in each direction
from the injury site were quantified. The majority of both hCNS-
SCns and hFb were found at regions 1 mm away from the injury
epicenter (an average of 77,18067,423 hCNS-SCns and an
average of 2,1966548 hFb) corresponding to the original sites of
transplantation. Few cells (an average of 1,6006276 hCNS-SCns
and an average of 147692 hFb) were recruited into the lesion site
Table 5. List of antibodies used for biochemical protein analysis (western blot).
Antibody Host Dilution Manufacturer Secondary Antibody Dilution Manufacturer
Fibronectin Rabbit 1:500 Sigma-Aldrich Amersham ECL Rabbit IgG, HRP-linked 1:10,000 GE Healthcare
GFAP Rabbit 1:40,000 DAKO Amersham ECL Rabbit IgG, HRP-linked 1:10,000 GE Healthcare
NG2 Rabbit 1:500 Chemicon Amersham ECL Rabbit IgG, HRP-linked 1:10,000 GE Healthcare
Versican Rabbit 1:400 Chemicon Amersham ECL Rabbit IgG, HRP-linked 1:10,000 GE Healthcare
PE-CAM1 Goat 1:500 R&D Systems Anti-goat IgG 1:500 Jackson Immunoresearch
doi:10.1371/journal.pone.0005871.t005
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day delayed transplantation, hCNS-SCns are capable of migration
in the injured spinal cord.
Human cell ablation using Diphtheria toxin at 16 weeks
post-transplant
It is possible that transplantation of a cell population after SCI
could recruit host cells capable of contributing to locomotor
recovery. Indeed, one study has demonstrated that while
transplanted Schwann cells stimulated host Schwann cell recruit-
ment, the grafted cells showed limited survival at the epicenter of a
contusion SCI, and represented a minority of total Schwann cells
present in the cavity two weeks post-transplantation [36].
However, if recovery in a given paradigm were mediated by
recruited host cells, one would predict that continued survival of
the transplanted cell population would not be required to maintain
behavioral improvement. In contrast to that study, our previous
Diphtheria toxin (DT) ablation of engrafted human cells
Figure 2. hCNS-SCns engraft, survive, and show limited proliferation in all transplanted animals; hFb engraft in all transplanted
animals, but demonstrate poor survival. A: Immunostaining using a human-specific cytoplasmic marker (SC121) demonstrated that hCNS-SCns
survived 17 weeks post-transplant. Brown indicates human cells visualized with DAB; Green indicates mouse and human nuclei visualized with methyl
green.B: Engrafted hCNS-SCns migrated away from the injury and appeared to differentiate in a site-specific manner with oligodendroglial and
neuronal morphologies in the white and grey matters, respectively. C: hFb also survived 17 weeks post-transplant, but were localized near the site of
transplantation (arrowhead).D: High power image of arrowhead in (C) demonstrated the presence of hFb at the site of injection.E: At 9dpi, animals
received either 75,000 hCNS-SCns or 50,000 hFb. Human cells engrafted in 100% of the animals. At 17 weeks post-transplant, an average of 194% of
the initial dose of hCNS-SCns and 7.5% of the initial dose of hFb were found in each animal, suggesting limited hCNS-SCns proliferation. Bars
represent group means6standard errors. Scale bars=250 mm for A and C and 25 mm for B and D.
doi:10.1371/journal.pone.0005871.g002
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for maintenance of functional locomotor recovery [1]. In the
present study, we quantified the number of human cells surviving
post-DT treatment in order to establish a numerical estimate of
ablation efficacy for this technique.
Histological analysis in animals receiving human cells at 9dpi
and 2 injections of DT at 16 weeks post-transplant demonstrated
an 80.5% reduction in the number of hCNS-SCns (Fig. 4C and D)
and 97.8% reduction of hFb (Fig. 5C and D) in comparison to
animals that received cells and were treated with saline at 16 weeks
post-transplant (Fig. 4A–B and Fig. 5A–B). Stereological quanti-
fication of the total number of engrafted human cells within the
defined region of 3 mm rostral and 3 mm caudal to the injury
epicenter revealed the presence of an average of 145,553612,940
hCNS-SCns (Fig. 4E) and an average of 3,7526790 hFb (Fig. 5E)
in animals receiving saline injection at 16 weeks post-transplant. In
comparison to the saline-treated animals, mice receiving DT
exhibited significantly less hCNS-SCns (an average of
28,45464,007) (Fig. 4E) and hFb (an average of 82645)
(Fig. 5E), demonstrating that DT ablated the human cells (1-tailed
t-tests: p,0.0001 for hCNS-SCns and p,0.0007 for hFb). It is
important to note that the estimated number of human cells in
animals treated with DT reported here is likely to be an
overestimation of intact, surviving cells. As shown in Fig. 4D,
apoptotic/necrotic appearing SC121-positive cells with nuclei and
a ‘‘foamy’’ appearance, but without processes, were detected in
animals receiving DT (arrowheads). However, in order to ensure
stereological consistency and reduce bias in quantification, all
SC121-positive human cells that were associated with methyl
green-positive nuclei were counted, whether or not they were
morphologically ‘‘unhealthy.’’ Accordingly, a conservative but
accurate estimate for the number of hCNS-SCns in the DT-
treated animals is reported. Collectively, these findings extended
and confirmed our previous observations that human cells are
ablated by administration of DT.
Stereological quantification for changes in the host
microenvironment
While improved locomotor recovery following 9dpi hCNS-
SCns transplantation was previously associated with cell integra-
tion within the host circuitry [1], the hypothesis that engrafted cells
could alter the host microenvironment as an additional mecha-
nism of recovery remained unexplored. In this study, we tested
that hypothesis by selecting multiple parameters of host response
that were most likely to undergo change following transplantation.
In the following sections, we discuss the effect of engrafted hCNS-
SCns in relationship to lesion volume, tissue sparing, serotonergic
fiber sprouting/regeneration, NG2 deposition, astrogliosis, and
angiogenesis. Stereological analyses of these parameters compare
three groups: vehicle, hFb, and hCNS-SCns. While a subset of
animals in each group received DT treatment at 16 weeks post-
transplant, unbiased stereology demonstrated no significant
differences in any of the parameters between DT- and saline-
treated animals, suggesting that the one week administration of
DT did not affect the host microenvironment. Thus, with the
exception of the correlative analyses, where only saline-treated
animals were analyzed, the means reported henceforth include all
animals within each group (vehicle, hFb, and hCNS-SCns), both
DT- and saline-treated.
Lesion volume and tissue sparing
The environment after trauma is dynamic and cell death
persists for weeks following SCI [37–39] resulting in an increase in
lesion size and a decrease in the spared tissue around the injury.
Delayed hCNS-SCns transplantation could reduce apoptosis/
necrosis by providing neurotrophic support to neurons and glia
[38–40]. Thus, we examined the potential contributions of
transplanted cells to changes in total lesion size and the amount
of tissue spared. To investigate the possibility that cells
transplanted at 9dpi affected the ongoing evolution of the injury
epicenter, estimated lesion volume was assessed using unbiased
Figure 3. hCNS-SCns migrate rostral and caudal to the injury; hFb migrate to a lesser extent. A: Estimated number of hCNS-SCns at
specific distances from the injury epicenter and along the spinal cord (shown in Fig. 1) was quantified. hCNS-SCns migrated at least 3 mm rostral and
3 mm caudal to the site of injury, but the majority of hCNS-SCns (average of 77,18067,423) were found at regions 1 mm rostral and caudal to the
lesion epicenter. B: Estimated number of hFb was quantified in the same manner as hCNS-SCns. While hFb were also found to migrate 3 mm rostral
and 3 mm cadudal to the lesion site, less hFb were found away from the injury epicenter compared to hCNS-SCns. The majority of hFb were also
found in regions 1 mm rostral and caudal to the injury site (average of 2,1966548) corresponding the original site of transplant. Bars represent group
means6standard errors.
doi:10.1371/journal.pone.0005871.g003
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defined as the area devoid of GFAP immunostaining and the
volume of this region (Fig. 6A) was quantified using the Cavalieri
estimator. No significant differences (One-way ANOVA: F=0.51,
p=0.60) were detected between any of the groups (vehicle, hFb,
and hCNS-SCns) in the estimated lesion volume (Fig. 6B).
To evaluate the amount of spared tissue proximal to the injury
epicenter and transplantation sites, the volume of intact tissue was
quantified in the same sections analyzed for lesion volume. Spared
tissue was defined within constrained regions extending 1 mm
rostral and caudal from the edge of injury epicenter, including
both white and grey matters (Fig. 6A). Cavalieri sampling in this
Figure 4. Diphtheria toxin (DT) administration at 16 weeks post-transplant ablates hCNS-SCns. A: Immunostaining using SC121
revealed cell survival in animals that received hCNS-SCns at 9dpi and saline injection at 16 weeks post-transplant. B: High power image of (A)
demonstrated the presence of healthy cells with staining of cytoplasm and processes. C: Animals receiving hCNS-SCns at 9dpi and DT at 16 weeks
post-transplant demonstrated a reduction in SC121 immunostaining. D: High power image of (C) demonstrated the presence of hCNS-SCns with
foamy appearance and/or morphological characteristics representative of unhealthy or apoptotic/necrotic cells (arrowheads). E: Quantification for
the estimated number of hCNS-SCns 17 weeks post-transplant revealed limited proliferation of hCNS-SCns in animals receiving saline at 16 weeks
post-transplant. Dashed line indicates the original transplanted dose of 75,000 hCNS-SCns. DT administration resulted in a significant reduction
(80.5%) in the number of hCNS-SCns. ** denotes p,0.0001, 1-tailed t-test. Means6standard errors are shown. Scale bars=250 mm for A and C and
25 mm for B and D.
doi:10.1371/journal.pone.0005871.g004
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p=0.82) between any of the groups in the estimated volume of
spared tissue (Fig. 6C). These data suggest that neither hCNS-SCns
nor hFb alter the lesion volume or volume of spared tissue.
Raphespinal regeneration/sprouting
The raphespinal tract is significantly involved in locomotor
function in rodents [41–43]. Additionally, because few serotoner-
gic (5-HT) cells are located within the spinal cord, the bulk of
raphespinal fiber immunostaining can be considered descending
[30], making it an appropriate tract for the assessment of fiber
regeneration/sprouting post-SCI. Regeneration/sprouting of the
5-HT fiber tract has been previously shown in several cell
transplantation models via grafting of BDNF and NT-3 producing
fibroblasts into injured rat spinal cords [11,14,41,44,45]. To
investigate the possibility that cells transplanted 9dpi affected
regeneration/sprouting of serotonergic fibers, unbiased stereolog-
ical quantification of 5-HT immunopositive fibers was performed
using the Isotropic Virtual Planes probe in a 500 mm long region
measured from the caudal edge of the lesion epicenter where
regenerating/sprouting fibers are found after injury (Fig. 7A).
Estimated fiber length was not significantly different (One-way
ANOVA: F=1.67, p=0.20) across any of the cell-treated groups or
vehicle control (Fig. 7B). This data suggests that neither hCNS-
SCns nor hFb promote regeneration and/or sprouting of host
serotonergic fibers.
NG2 deposition
During the chronic phases of injury, an astroglial scar, which
has been suggested to be non-permissive to axonal regeneration,
Figure 5. Diphtheria toxin (DT) administration at 16 weeks post-transplant ablates hFB. A: Immunostaining using SC121 illustrated
limited cell engraftment/survival (inset) in animals that received hFb at 9dpi and saline injection at 16 weeks post-transplant. B: High power image of
inset in (A) revealed the presence of hFb near the site of transplantation. C: Animals receiving hFb at 9dpi and DT at 16 weeks post-transplant
demonstrated a reduction in SC121 immunostaining. D: High power image of (C) demonstrated the absence of SC121 immunoreactivity in animals
receiving DT at 16 weeks post-transplant. E: Quantification for the estimated number of hFb in animals receiving saline at 16 weeks post-transplant
revealed limited survival. Dashed line indicates the original transplanted dose of 50,000 hFb. DT administration resulted in a significant reduction in
the number of hFb (97.8%) suggesting that DT ablated the transplanted human cells. * denotes p,0.0007, 1-tailed t-test. Means6standard errors are
shown. Scale bars=250 mm for A and C and 25 mm for B and D.
doi:10.1371/journal.pone.0005871.g005
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identified as the region devoid of GFAP immunostaining. Regions 1 mm rostral and 1 mm caudal to the border of the lesion were selected for
assessment of spared tissue. B: Volume assessments were performed using the Cavalieri estimator probe of StereoInvestigator and revealed no
significant differences in the estimated lesion volume between any of the groups (One-way ANOVA: F=0.51, p=0.60). C: No significant differences
were found in the estimated volume of spared tissue between any of the groups (One-way ANOVA: F=0.20, p=0.82). Scale bar=250 mm.
doi:10.1371/journal.pone.0005871.g006
Figure 7. Human cell transplantation does not alter raphespinal sprouting/regeneration. A: A contour was drawn around a 500 mm long
region at the caudal edge of the lesion epicenter and 5-HT fiber length in this area was quantified using the Isotropic Virtual Planes probe of
StereoInvestigator. B: Stereological analysis revealed no significant differences in the estimated raphespinal fiber length between any of the groups
(One-way ANOVA: F=1.67, p=0.20). Scale bar=250 mm.
doi:10.1371/journal.pone.0005871.g007
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ment after SCI, however, is not limited to astrogliosis. A wide
variety of extracellular matrix molecules in the CSPG family,
including NG2, brevican, versican, and neurocan are also
differentially up-regulated after injury [46–50], and have been
shown to limit neurite outgrowth [51–53]. Numerous studies in
rats have assessed CSPG deposition after SCI using a pan-CSPG
antibody [46,54–56]. Other studies performed in mice have also
reported CSPG deposition post trauma using the same antibody
[57]. However, due to the monoclonal nature of available anti-
CSPG antibodies and our animal model (mouse), we were
unsatisfied with the level of specificity with this approach (data
not shown). We therefore sought to test the possible cell-mediated
changes in deposition of a more specific CSPG, the NG2
proteogylcan.
NG2 is a major CSPG component that is elevated starting 24
hours after injury, remaining significantly above control levels for
up to 6 months post-SCI, and is inhibitory to neurite outgrowth in
vitro [58–60] and in vivo [58,59,61]. Previous transplantation
studies have demonstrated the capacity of embryonic radial glia to
reduce NG2 deposition, thus promoting axonal regeneration [54].
In order to investigate the effect of cell transplantation at 9dpi on
NG2 deposition, stereological quantification of the area occupied
by the NG2 proteoglycan (Fig. 8A) was performed using the
Cavalieri estimator. No significant differences (One-way ANOVA,
F=0.005, p=0.99) were found in the area occupied by the NG2
proteogylcan between any of the groups (Fig. 8B). This data
suggests that neither hCNS-SCns nor hFb alter deposition of the
NG2 proteoglycan following injury.
GFAP astrogliosis
Following CNS trauma, astrocytes proliferate, hypertrophy, and
extend processes, walling off the region around the injury
epicenter [62]. Acutely after SCI, astrocytes may serve a beneficial
role by mediating repair of the blood-brain barrier [17,63]. In
more chronic phases of injury, however, reactive astrocytes have
been suggested to inhibit neurite outgrowth by operating as a
chemical barrier by releasing a variety of CSPGs, as discussed
above, and as a complex, three-dimensional physical barrier
[52,58,59,64]. While we did not observe any changes in deposition
of the scar-associated NG2 proteoglycan as a result of cell
transplantation, the possibility that engrafted cells modified the
physical component of astrogliosis remained unclear. In this
experiment, we investigated the effect of cell transplantation at
9dpi on the size of the astroglial scar. Stereological quantification
for the area surrounding the injury epicenter and containing dense
GFAP-positive immunostaining indicative of the glial scar (Fig. 8C)
was performed using the Cavalieri estimator probe. No significant
differences (One-way ANOVA, F=1.50, p=0.24) in the area
occupied by the GFAP astroglial scar were found between any
of the groups (Fig. 8D). These findings suggest that neither hCNS-
SCns nor hFb alter astrogliosis when compared to vehicle control.
Further, it suggests that hCNS-SCns do not contribute to the
astroglial scar by recruitment of host GFAP cells.
Angiogenesis
Spinal cord injury directly affects the permeability of the blood-
brain/spinal barrier and damages the spinal cord vasculature.
Application of a number of treatments following CNS trauma has
Figure 8. Human cell transplantation does not alter the areas of NG2 deposition or the GFAP astroglial scar. A: Estimated area
occupied by the NG2 proteoglycan was analyzed using the Cavalieri estimator probe of StereoInvestigator. B: Quantification revealed no significant
differences between any of the groups in the area occupied by NG2 (One-way ANOVA: F=0.005, p=0.99). C: Estimated area occupied by the GFAP
scar was determined in the same manner as NG2. The lesion epicenter was not included in the estimated GFAP scar area. D: Stereological
quantification exhibited no significant differences between any of the groups in the area of the GFAP astroglial scar (One-way ANOVA: F=1.50,
p=0.24). Scale Bar=250 mm for A and C.
doi:10.1371/journal.pone.0005871.g008
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vascular remodeling [65,66]. Notably, transplantation of OECs
after a variety of PNS and CNS injury paradigms has been shown
to modulate angiogenesis either directly via an increase in blood
vessel density [67] or indirectly by an increase in endothelial-
associated growth factors [68]. We tested the hypothesis that cell
transplantation mediates spinal cord vasculature repair using
immunostaining with PE-CAM1 (platelet/endothelial cell adhe-
sion molecule). Blood vessel length was quantified using the Space
Balls probe of StereoInvestigator in two regions: 1) at the injury
epicenter and 2) 1 mm rostral and 1 mm caudal to the edge of the
lesion (Fig. 9A and B). While there was a trend for increased blood
vessel length at regions 1 mm rostral and 1 mm caudal to the
injury epicenter in transplanted animals compared to control
groups, this difference did not achieve statistical significance (One-
way ANOVA, F=1.87, p=0.17) (Fig. 9C). Similarly, no significant
differences were found at the lesion site (One-way ANOVA, F=0.65,
p=0.53) (Fig. 9D). These findings suggest that neither hCNS-SCns
nor hFb modify revascularization after SCI.
Biochemical protein analyses
The histological absence of significant differences in the multiple
parameters of host response after hCNS-SCns transplantation was
supplemented with biochemical analyses to determine protein
expression levels in spinal cord-injured animals receiving either
hCNS-SCns or vehicle at 9dpi. We hypothesized that the
maximum potential for trophic/neuroprotective modulation of
host repair mechanisms by transplanted cells would occur within
the first 2 weeks following transplantation because lesion volume,
tissue sparing, astroglial scar formation and proteoglycan deposi-
tion become relatively stable within 2–3 weeks following rodent
contusion SCI [69–72]. Hence, assessment of a supplemental set of
biochemical markers for host repair at this additional time point of
2 weeks post-transplantation would have both the potential to
reveal any changes missed in our analyses at 4 months post-
transplantation, and the potential to reveal any changes that may
have occurred acutely but transiently after transplantation.
Accordingly, western blot analysis to assess possible changes in
protein expression levels of fibronectin, an extracellular matrix
molecule present at the lesion epicenter of injured mice, revealed
no significant differences (2-tailed t-test: p=0.234) between animals
receiving hCNS-SCns and vehicle (Fig. 10A), suggesting that
hCNS-SCns transplantation does not alter fibronectin deposition
at 2 weeks post-transplant. The protein expression levels of two
CSPG proteins, NG2 and Versican, which have been shown to
increase acutely after injury and remain upregulated for prolonged
periods following SCI, also did not change (2-tailed t-test: p=0.477
for NG2 and p=0.299 for Versican) as a result of hCNS-SCns
transplantation (Fig. 10B and C). Further, GFAP protein
expression (Fig. 10D), an indication of glial scarring, and PE-
CAM1 expression (Fig. 10E), indicative of potential angiogenesis,
were not different between transplanted animals and vehicle
control (2-tailed t-test: p=0.581 for GFAP and p=0.496 for PE-
CAM1). Protein expression level of b-actin, which was used to
ensure equivalent protein loading, demonstrated no significant
differences (2-tailed t-tests: p=0.116) between transplanted animals
and vehicle control (Fig. 10F). Collectively, these data supplement
our stereological quantification suggesting that hCNS-SCns
Figure 9. Human cell transplantation does not alter angiogenesis. A: Estimated length of blood vessels at the injury epicenter and at regions
1 mm rostral and 1 mm caudal to the lesion site were quantified using the Space Balls probe of StereoInvestigator. B: The injury epicenter was
identified using DAPI immunofluorescent staining within the PE-CAM1-stained sections. C: While there was a trend toward an increase in blood
vessel length at regions 1 mm rostral and caudal to the lesion, this difference was not statistically significant (One-way ANOVA: F=1.87, p=0.17). D:
No significant differences in the blood vessel length were detected between the groups at the injury epicenter (One-way ANOVA: F=0.65, p=0.53).
Scale Bar=250 mm for A and B.
doi:10.1371/journal.pone.0005871.g009
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PLoS ONE | www.plosone.org 13 June 2009 | Volume 4 | Issue 6 | e5871Figure 10. Expression levels of proteins associated with host repair remain unchanged as a result of hCNS-SCns transplantation.
Biochemical analysis was performed 2 weeks post-transplant in animals that received either hCNS-SCns or vehicle control. A: No changes in
Fibronectin protein expression were observed as a result of hCNS-SCns transplantation (2-tailed t-test: p=0.234). B: Protein analysis of a CSPG protein,
NG2, demonstrated no significant differences between transplanted animals and vehicle control (2-tailed t-test: p=0.477). C: Expression levels of an
additional CSPG protein, Versican, revealed no significant differences between the two groups (2-tailed t-test: p=0.299). D: GFAP protein expression
remained unchanged as a result of hCNS-SCns transplantation (2-tailed t-test: p=0.581). E: PE-CAM1 expression levels were not altered after cell
transplantation (2-tailed t-test: p=0.496). F: b-actin was used as control to ensure equivalent protein loading (2-tailed t-test: p=0.116).
doi:10.1371/journal.pone.0005871.g010
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glial scarring, and re-vascularization.
Correlative analyses
We have previously shown that hCNS-SCns, but not hFb,
improved locomotor recovery assessed by the horizontal ladder-
beam task after 9 day delayed transplantation into the injured
spinal cord [1]. In the present study, we demonstrated that hCNS-
SCns survived and migrated 17 weeks post-transplant and
administration of DT ablated the human cells. Additionally, we
found no evidence of host modification in transplanted animals,
suggesting that cell transplantation does not alter endogenous
repair mechanisms. However, the possibility that the number of
engrafted cells affected behavioral and histological recovery
remained unexplored. To further investigate this relationship, we
performed regression analyses for the total number of engrafted
human cells and behavioral/histological host recovery. All
correlation analyses were performed in the subset of animals
receiving human cells at 9dpi and saline at 16 weeks post-
transplant (Table 2). As shown previously (Figs. 4 and 5), DT
ablated 80.5% of hCNS-SCns and 97.8% hFb; for this reason,
animals receiving DT were excluded from regression analyses.
Linear regression analysis revealed a significant negative
correlation (Pearson r: r=20.78, p=0.038, 2-tailed t-test) between
the estimated number of engrafted hCNS-SCns and the number of
errors made on the horizontal ladderbeam (Fig. 11A). Interest-
ingly, a positive but non-significant, correlation (Pearson r: r=0.49,
p=0.26, 2-tailed t-test) was found between the estimated number of
hFb and the number of errors made on the ladderbeam task
(Fig. 12A), suggesting a trend for decreased behavioral recovery
with an increase in hFb engraftment. These data extend and
confirm our previous findings and suggest that hCNS-SCns, but
not hFb engraftment is critical for locomotor recovery.
Analyses of other measures of host recovery revealed no
significant correlations between cell engraftment and any param-
eters of host repair. No significant correlations were found
between hCNS-SCns engraftment and lesion volume (Pearson r:
r=20.70, p=0.08, 2-tailed t-test) as shown in Fig. 11B. In a
contrasting yet still non-significant trend, no correlations between
hFb engraftment and lesion volume (Fig. 12B) were detected
Figure 11. hCNS-SCns engraftment directly correlates with a quantitative measure of behavior, but not other measures of
histological recovery. A: Linear regression analysis revealed a significant negative correlation between hCNS-SCns engraftment and the number of
errors made on the horizontal ladderbeam task (Pearson r=20.78, p=0.038, 2-tailed t-test). B-D: Linear regression analyses for the estimated number
of hCNS-SCns and other measures of host recovery revealed no significant correlations between cell engraftment and lesion volume (B) (Pearson
r=20.70, p=0.08, 2-tailed t-test), volume of spared tissue (B) (Pearson r=0.42, p=0.34, 2-tailed t-test), serotonergic fiber sprouting (C) (Pearson
r=0.16, p=0.77, 2-tailed t-test), NG2 area (D) (Pearson r=0.16, p=0.77, 2-tailed t-test), and area of the GFAP astroglial scar (D) (Pearson r=20.69,
p=0.08, 2-tailed t-test). * denotes p,0.05.
doi:10.1371/journal.pone.0005871.g011
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absence of a significant correlation between hCNS-SCns engraft-
ment and the volume of spared tissue (Pearson r: r=20.40, p=0.37,
2-tailed t-test); similarly, as shown in Fig. 12B, hFb engraftment did
not correlate with tissue sparing (Pearson r: r=0.55, p=0.21, 2-tailed
t-test). Correlation analysis of hCNS-SCns engraftment with
serotonergic fiber length (Fig. 11C) demonstrated no significant
correlations between these two measures (Pearson r: r=0.42,
p=0.34, 2-tailed t-test); once again, in contrast to the positive yet
non-significant trend for increased fiber sprouting in animals
receiving hCNS-SCns, hFb engraftment (Fig. 12C) resulted in a
negative but non-significant trend (Pearson r: r=20.53, p=0.22, 2-
tailed t-test). Finally, no significant correlations between hCNS-
SCns engraftment and NG2 area (Pearson r: r=0.16, p=0.77, 2-
tailed t-test), and between hCNS-SCns engraftment and GFAP-
positive astrogliosis (Pearson r: r=20.69, p=0.09, 2-tailed t-test)
were observed (Fig. 11D), although the latter demonstrated a
strong trend for reduction in astroglial scarring with an increase in
hCNS-SCns engraftment. hFb engraftment also did not correlate
with the area occupied by the NG2 proteoglycan (Fig. 12D)
(Pearson r: r=0.01, p=0.98, 2-tailed t-test); as well, no significant
correlations between hFb engraftment and GFAP-positive astro-
gliosis (Pearson r: r=0.22, p=0.63, 2-tailed t-test) were observed
(Fig. 12D), but interestingly and again in contrast to hCNS-SCns,
there was a strong yet non-significant trend for an increase in
astroglial scarring with an increase in hFb number. Altogether,
these data suggest that increased hCNS-SCns engraftment may
result in reduced lesion size and astroglial scarring while hFb may
exacerbate those measures of recovery. Correlative analysis for
angiogenesis and hCNS-SCns/hFb engraftment could not be
performed because the number of saline-treated animals with
identifiable injury epicenters was too low (n=4 for hCNS-SCns
and n=5 for hFb) to obtain reliable correlative results.
Collectively, our findings do not provide conclusive evidence that
an increase in hCNS-SCns number is more beneficial for
recovery- a question currently under further investigation, but
not within the scope of the current study. However, our data
demonstrate that hCNS-SCns, but not hFb, survival and
engraftment are directly related to a quantitative measure of
behavioral recovery but not other measures of histological
outcome. Notably, these results suggest that an increase in
hCNS-SCns number does not have detrimental effects on lesion
Figure 12. hFb engraftment does not correlate with behavioral or histological measures of recovery. A: In contrast to hCNS-SCns, linear
regression analysis revealed a positive, but non-significant correlation between hFb engraftment and the number of errors made on the horizontal
ladderbeam task (Pearson r=0.49, p=0.26, 2-tailed t-test). B–D: Linear regression analyses for the estimated number of hFb and other measures of
host recovery revealed no significant correlations between cell engraftment and lesion volume (B) (Pearson r: r=0.59, p=0.16, 2-tailed t-test), volume
of spared tissue (B) (Pearson r: r=0.55, p=0.21, 2-tailed t-test), serotonergic fiber sprouting (C) (Pearson r: r=20.53, p=0.22, 2-tailed t-test), NG2 area
(D) (Pearson r: r=0.01, p=0.98, 2-tailed t-test), and area of the GFAP astroglial scar (D) (Pearson r: r=0.22, p=0.63, 2-tailed t-test).
doi:10.1371/journal.pone.0005871.g012
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Discussion
In our previous study, we reported locomotor recovery in
NOD-scid mice receiving 60 kd contusion injuries and hCNS-
SCns transplantation at 9dpi. Immuno-electron microscopy
revealed evidence for human cell remyelination of mouse axons,
the formation of putative human-mouse synapses, and ablation of
human cells using DT abolished the observed recovery, suggesting
that hCNS-SCns integrated within the host circuitry [1]. However,
the hypothesis that hCNS-SCns altered the host microenviron-
ment as an additional mechanism of recovery remained
unexplored. In the present study, we tested this hypothesis and
demonstrated that hCNS-SCns survived and migrated, and 80.5%
of the transplanted cells were ablated after DT administration. No
evidence for stereological and biochemical changes in the host
microenvironment was found in animals transplanted with hCNS-
SCns versus hFb or vehicle control mice. Notably, a negative and
significant correlation was detected between hCNS-SCns (but not
hFb) engraftment and the number of errors made on the
horizontal ladderbeam task suggesting that survival/engraftment
of a specific cell population (hCNS-SCns) is directly related to a
quantitative measure of recovery. Human cell engraftment did not
correlate with any other histological measures of recovery.
Collectively, these data support the hypothesis that hCNS-SCns
transplantation at 9dpi results in behavioral recovery via cell
integration within the host circuitry.
Engraftment and survival
A wide array of stem cell transplantation strategies has been
tested for the potential to promote recovery in animal models of
SCI. These include, but are not limited to, OECs [10,45,67,73],
bone marrow stromal cells [74,75], Schwann cells [36,44],
genetically-modified fibroblasts [9,11,41,76], embryonic-derived
neural/glial stem cells [2,4,6], and fetal/adult NSCs [1,3,5,7,77].
While cell transplantation in many of these studies has been
reported to result in improved recovery of function, engraftment
and survival of the transplanted population have been, in most
cases, either partially investigated or not addressed at all.
Moreover, the number of animals with successful engraftment is
often not reported. While it may be possible for trophic/
neuroprotective effects of cell-mediated host repair to persist even
if exogenous cells are lost in a delayed fashion, long-term survival
of a transplanted cell population is critical in studies that report
recovery of function associated with cell replacement and/or
integration within the host circuitry, as in the case of our previous
publication. In that regard, the NOD-scid mouse is the model of
choice for xenograft experiments because of the ability to achieve
successful engraftment in 100% of transplanted animals and long-
term survival of xenografted cells. NOD-scid mice are widely used
in human hematopoietic cell transplantation research [78]. We
have previously extended the use of NOD-scid mice to include the
CNS [18,19] and observed high levels of engraftment and long-
term hCNS-SCns survival in the neonatal brain. Thus, in order to
achieve adequate control over host immunorejection in the injured
rodent spinal cord, in this study, we chose the NOD-scid mouse
model and report that 100% of transplanted animals exhibited
engraftment of hCNS-SCns and hFb after a 9 day delayed
transplantation.
An alternative approach for xenogeneic/allogeneic transplants
is modulation of the immune response via administration of
immunosuppressant drugs. However, the efficacy of long-term
engraftment using pharmacological immunosuppressants is either
not reported in most studies or appears to be limited. Only few
studies transplanting NSCs into the injured spinal cord of
immunosufficient animals receiving either cyclosporine or tacro-
limus have attempted to numerically quantify total cell numbers at
the time of sacrifice and report poor cell survival, ranging from
0.1%–37% [3,5,79,80]. Critically, to our knowledge, only one
study transplanting human NSCs into the spinal cord-injured
immunodeficient athymic rat has reported a 375% increase
(assessed by stereological methods) in total cell numbers at 6
months post-transplant [7]. Thus, it appears that pharmacological
immunosuppression by means of cyclosporine or tacrolimus alone
may be insufficient to obtain long-term survival. Additionally, in
the clinical setting, neurotoxicity is one of the most widely reported
side effects of both of these immunosuppressant drugs [81,82].
Similarly, administration of immunosuppressant agents may cause
toxicity in animals resulting in illness and poor behavioral
performance. Finally, the effects of immunosuppressant drugs on
cell fate and mechanisms of recovery remain largely unexplored.
Altogether, these data suggest that the use of a constitutively
immunodeficient model avoids the possible confounds of immu-
nosuppressant drugs while providing an adequate transplantation
environment where empirical hypotheses about cell survival and
mechanisms of recovery could be tested. In the current study,
stereological quantification of human cells transplanted into the
immunodefiicent microenvironment revealed: 1) successful en-
graftment of human cells in 100% of animals receiving either
hCNS-SCns or hFb; 2) limited proliferation of hCNS-SCns (194%
of the number originally transplanted) and poor engraftment/
survival of hFb (7.5% of the number originally transplanted) at 17
weeks post-transplant.
Factors influencing cell-mediated potential for repair of
neurotrauma
Multiple mechanisms by which engrafted stem cells could either
directly integrate with the host or indirectly affect the host
microenvironment following CNS injury have been proposed. Yet,
few studies transplanting stem cell populations have thoroughly
addressed the mechanisms of recovery following engraftment. We
have previously shown evidence for cell integration after 9 day
delayed hCNS-SCns transplantation into NOD-scid mice. In the
present study, further analysis of transplanted animals demon-
strated no changes in the host microenvironment as measured by
lesion size and tissue sparing, serotonergic regeneration/sprouting,
NG2 deposition, glial scarring, and angiogenesis as measured by
stereology. Additionally, biochemical protein analysis supplement-
ed our stereological quantification and demonstrated no changes
in protein expression levels of Fibronectin, NG2, Versican, GFAP,
and PE-CAM1 at 2 weeks post-transplant. Collectively, the
stereological and biochemical analyses suggest that transplantation
of hCNS-SCns into contusion injured NOD-scid mice at 9dpi does
not result in changes within the host microenvironment. While it is
possible that other measures of recovery not assessed in the current
study have undergone change as a result of hCNS-SCns
transplantation, we drew on the current literature in order to
select the most likely candidates for host modification. We expect
that a number of factors could influence the potential repair
mechanisms of the transplanted cells.
One variable that may influence the capacity of cells for
neurorepair is the nature of the transplanted cell population. The
source of transplanted NSCs (i.e. murine vs. human, ES vs. fetal)
could affect the interpretation of SCI studies addressing mecha-
nisms of recovery in vivo. Diversity in the source of original cell
populations, methods of isolation, and preparation of cells could
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microenvironment. In the current study, we use a human NSC
population that is prospectively isolated based on FACS to identify
a CD133
+ and CD24
2/lo population. This process theoretically
selects for a NSC-enriched population; accordingly, these cells
exhibit approximately a 2000-fold enhancement in neurosphere
initiating capacity [18]. It is unknown whether the cell intrinsic-
properties of NSCs isolated by this or similar methods differ from
other NSC populations; however, it is possible that selection for
specific markers could alter either the response of the cells to the
microenvironment or, conversely, the effect of the microenviron-
ment on the cells.
Another variable that may affect the potential mechanisms of
recovery is the nurture of the cell population. Both the heterogeneity
and differentiation capabilities of NSCs could be affected by the
method used to derive and culture the cells as either a monolayer
[7,83–86] or as neurospheres [87] prior to transplantation. When
cultured under conditions that do not promote differentiation,
NSCs grown as monolayers can retain their multipotent capacity
and give rise to neural precursor/progenitor populations
[85,86,88]. When expanded as neurospheres, NSCs represent a
heterogeneous population of both multipotent neural stem cells
and more restricted progenitors [89]. It is possible that cells grown
as monolayers versus neurospheres, as is the case in the present
study, would not behave in the same manner in an in vivo setting
and thus affect the mechanisms of recovery.
Finally, the niche into which the cells are transplanted could
override the intrinsic properties of transplanted cells and affect
mechanisms of recovery. The niche can be defined by the animal
model, the injury paradigm, location of the transplant, presence or
absence of immunosuppression, and time of transplantation. In the
present study, hCNS-SCns were transplanted at 9dpi into the
intact spinal cord parenchyma of contused NOD-scid mice. As
discussed earlier, our animal model was selected to obtain
successful cell engraftment and to avoid confounds of immuno-
suppressant agents, which are often used in SCI transplantation
studies.
Another aspect of the niche is the type of injury. In this study,
we used the clinically relevant experimental model of contusion
injury. According to the National Spinal Cord Injury Statistical
Center, motor vehicle crashes, the most common type of contusion
injuries, account for 42% of reported SCI cases in humans. In
animal models, contusion injuries are induced by exposing the
spinal cord to mechanical trauma while the dura is maintained
intact [72,90–92]. Contusion injury results in neuronal apoptosis
as well as oligodendroglial cell death rostral and caudal to the
lesion site beginning at 6 hours and extending to at least 3 weeks
post-injury [38,93]. Further, contusion injury has been shown to
preferentially target the large caliber axons [94], suggesting
neuronal damage, oligodendroglial loss, and subsequent demye-
lination post-trauma. Spinal cord pathology following contusion
injury is also accompanied by a prolonged secondary inflamma-
tory response [95] that includes the activation of resident microglia
and recruitment of immune cells, such as macrophages, rostro-
cuadal to the injury epicenter, and especially in the white matter
[96,97], suggesting phagocytosis of myelin debris. In contrast,
transection of the spinal cord results in a narrow zone of primary
tissue damage that is followed by a focal secondary pathological
and inflammatory response [97]. Cell death following transection
models of injury is thought to affect neurons and glia indiscrim-
inately and morphological analyses of dying cells in the transected
cord suggests a necrotic mechanism [98]. Collectively, these data
suggest that the experimental injury paradigm is a critical factor in
defining the host niche post-trauma.
In the present study, hCNS-SCns were transplanted into the
intact parenchyma of the spinal cord near the lesion site but not
directly into the injury epicenter. This was done for two reasons: 1)
While rats and most humans form a cavity at the lesion epicenter
after SCI, mice develop a fibronectin-rich matrix at the injury site
[99]. This compact meshwork of cells and connective tissue may
limit the injection volume for transplantation. 2) The initial peak of
inflammatory CD11b/ED1-positive cells in the rodent injury
epicenter occurs at 7–14dpi [37,95]. The presence of this
phagocytic cell population at the injury site suggests that the
epicenter may not be a favorable environment for cell survival,
and the effects of myeloid cells on fate potential have not been
thoroughly investigated. Further, proinflammatory cytokines, such
as IL-1b, peak at 12 hrs post-SCI but are found for up to at least
28 dpi [100]. Other cytokines such as TNF-a and IFN-c have also
been detected at elevated levels in the injury epicenter at 7dpi
[101]. Collectively, these data suggest that at 9dpi, the injury
epicenter may not afford optimal cell survival. Thus, we
transplanted hCNS-SCns into the relatively normal parenchyma
adjacent to the lesion site.
Finally, most transplantation studies after SCI are performed
within a ‘‘therapeutic window’’ of 7–14dpi when the potential for
cell replacement is thought to be optimal [102]. However, cell
replacement is not the only means by which transplanted cells
could promote recovery of function. Several studies have suggested
that acute (0–5dpi) transplantation of NSCs and neural progenitor
cell populations can promote recovery by alternative mechanisms,
e.g. via modification of the host niche [12,13,15]. In the present
study, we tested this hypothesis for hCNS-SCns engraftment at a
slightly more delayed timepoint of 9dpi and found no changes in
the host microenvironment as a result of hCNS-SCns transplan-
tation. It is possible that shortening the delay between SCI and cell
transplantation may drive the transplanted cells to serve a more
trophic role and alter the host microenvironment. Alternatively,
the mechanisms mediating recovery of function may be cell
population-specific.
Finally, contusion/compression injuries comprise the majority
of human spinal cord injuries, and most injuries of this type are
categorized as anatomically incomplete, suggesting the presence of
spared host axons and circuitry post-injury [103–105]. Contusion
SCI models in rodents recapitulate many features of clinical
contusion/compression injuries, suggesting that understanding the
mechanisms of recovery, i.e. integration versus stimulation of host-
mediated repair, will yield insight into strategies for the treatment
of clinical SCI, and the appropriate timing for potential cellular
therapeutic interventions.
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